Zevra Therapeutics
ZVRA
2 hedge funds and large institutions have $19K invested in Zevra Therapeutics in 2020 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, reducing their positions, and 1 closing their positions.
0% more funds holding
Funds holding: 2 → 2 (0)
0% more first-time investments, than exits
New positions opened: 1 | Existing positions closed: 1
0.06% less ownership
Funds ownership: 0.06% → 0.01% (-0.06%)
25% less capital inflows, than outflows
Capital inflows: $18.7K | Capital outflows: $25K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
IA
IFP Advisors
Tampa,
Florida
|
+$14K |
| 2 |
Carson Wealth (CWM LLC)
Omaha,
Nebraska
|
+$4.68K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ISB
Iowa State Bank
Urbandale,
Iowa
|
-$25K |
ZVRA Hedge Fund Activity: Q4 2020 in Review
2 of the 5,678 institutional investors tracked by Wall St. Rank reported a position in Zevra Therapeutics (ZVRA) for Q4 2020, worth a combined $19K — down 37% from $30K a quarter earlier.
Fund positioning in ZVRA was balanced in Q4 2020: 1 fund opened new positions, 1 closed out, 1 added to existing stakes and 0 trimmed.
The largest buyer was IFP Advisors, opening a new position worth an estimated $14K. The largest seller was Iowa State Bank, exiting entirely with an estimated $25K sold.
- 2 institutional investors held Zevra Therapeutics (ZVRA) as of Q4 2020, unchanged from Q3 2020.
- Funds reported $19K of Zevra Therapeutics stock for Q4 2020, down 37% quarter-over-quarter.
- 1 fund opened new Zevra Therapeutics positions in Q4 2020 and 1 closed out, a net change of 0 holders.
- The largest Zevra Therapeutics buyer in Q4 2020 was IFP Advisors, an estimated $14K added.
- The largest Zevra Therapeutics seller in Q4 2020 was Iowa State Bank, an estimated $25K sold.
Based on aggregated 13F filings for Q4 2020.